Teva Might Be Getting Sicker As The Stock Drops


Teva's problem - Bad can get worse

Sometimes a stock is a better sell at a lower price than it was at the prior, higher price range; that might the case for Teva Pharmaceutical (NYSE:TEVA) now. This happened to me in the spring of 2014 with an oil driller, Tidewater (NYSE:TDW). I managed to lose 10% in the stock just as I was transitioning from bullish on the shale revolution to bearish on oil prices. I bought TDW around $55 and sold near $50 pre-split. Now it is at $27 post-split. The split? It was a reverse split, where 1000 shares turned into only 31 shares. If I had not sold at $50, I would have essentially lost all my money in the stock. This was one of the few times where I lost money in a stock and felt grateful that I made a very good decision. I had made lots of money in energy plays between 2010 and 2014, and one loss was just the price of playing the game.


It's on us. Share your news here.

Submit your stories and articles to citybizlist today.